On June 1, 2020 Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, reported its participation in two upcoming investor conferences. Chief Executive Officer and Co-Founder Sheila Gujrathi, M.D., will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, at 3:00 p.m. ET and at the 41st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, at 2:10 p.m. ET (Press release, Gossamer Bio, JUN 1, 2020, View Source [SID1234560735]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live webcasts of both presentations will be available on the "Events and Presentations" page in the "Investors" section of the company’s website at View Source Replays of each webcast will be archived on the company’s website for 90 days following the presentation.